Literature DB >> 3612956

Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes.

J Taylor, W Mason, J Summers, J Goldberg, C Aldrich, L Coates, J Gerin, E Gowans.   

Abstract

We obtained two lines of evidence that monolayer cultures of primary woodchuck hepatocytes support replication of the genome of human hepatitis delta virus (HDV). (i) From a Northern (RNA blot) analysis of the HDV-related RNA in infected cultures, both genomic and antigenomic 1.7-kilobase RNA species were detected at 11 days after infection. The ratio of genomic RNA to antigenomic RNA was 2:1 to 10:1, comparable to that previously reported in studies of experimentally infected chimpanzees and woodchucks. (ii) Replication in culture was also demonstrated by in situ hybridization with a strand-specific probe. Such studies showed that only a small fraction of the cultured cells supported replication and that in such cells the relative and absolute levels of the HDV RNAs were comparable to those in liver cells infected in vivo. Furthermore, as with the in vivo studies, the HDV RNAs were predominantly localized to the nucleus. In summary, we demonstrated that cultured cells supported both the early events of HDV adsorption and penetration and the intermediate events of genome replication.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612956      PMCID: PMC255813     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Nigrosin as a dye for differentiating live and dead ascites cells.

Authors:  J P KALTENBACH; M H KALTENBACH; W B LYONS
Journal:  Exp Cell Res       Date:  1958-08       Impact factor: 3.905

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Hybridization of denatured RNA transferred or dotted nitrocellulose paper.

Authors:  P S Thomas
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Delta hepatitis agent: structural and antigenic properties of the delta-associated particle.

Authors:  F Bonino; B Hoyer; J W Shih; M Rizzetto; R H Purcell; J L Gerin
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.

Authors:  A Ponzetto; P J Cote; H Popper; B H Hoyer; W T London; E C Ford; F Bonino; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

8.  Cloned fragment of the hepatitis delta virus RNA genome: sequence and diagnostic application.

Authors:  K J Denniston; B H Hoyer; A Smedile; F V Wells; J Nelson; J L Gerin
Journal:  Science       Date:  1986-05-16       Impact factor: 47.728

9.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.

Authors:  M Rizzetto; B Hoyer; M G Canese; J W Shih; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  38 in total

1.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  Editing on the genomic RNA of human hepatitis delta virus.

Authors:  H Zheng; T B Fu; D Lazinski; J Taylor
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Prominent polypurine and polypyrimidine tracts in plant viroids and in RNA of the human hepatitis delta agent.

Authors:  A D Branch; S E Lee; O D Neel; H D Robertson
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

5.  Introduction of hepatitis delta virus into animal cell lines via cationic liposomes.

Authors:  V Bichko; H J Netter; J Taylor
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Experimental transmission of human hepatitis delta virus to the laboratory mouse.

Authors:  H J Netter; K Kajino; J M Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.

Authors:  J C Wu; P J Chen; M Y Kuo; S D Lee; D S Chen; L P Ting
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Localization of hepatitis delta virus RNA in the nucleus of human cells.

Authors:  C Cunha; J Monjardino; D Cheng; S Krause; M Carmo-Fonseca; D Chang
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

10.  Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity.

Authors:  M F Chang; S C Baker; L H Soe; T Kamahora; J G Keck; S Makino; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.